BODY MASS INDEX AS A PROGNOSTIC FACTOR FOR DISEASE PROGRESSION IN PATIENTS WITH METASTATIC COLORECTAL CANCER TREATED WITH BEVACIZUMAB BASED SYSTEMIC THERAPY

由 Hopirtean, C., Ciuleanu, T., Cainap, C., Todor, N., Nagy, V.
發表在 Acta Endocrinol (Buchar) (2017)

Erlotinib therapy after initial platinum doublet therapy in patients with EGFR wild type non-small cell lung cancer: results of a combined patient-level analysis of the NCIC CTG BR...

由 Osarogiagbon, Raymond U., Cappuzzo, Federico, Ciuleanu, Tudor, Leon, Larry, Klughammer, Barbara
發表在 Transl Lung Cancer Res (2015)

First-line gefitinib in Caucasian EGFR mutation-positive NSCLC patients: a phase-IV, open-label, single-arm study

由 Douillard, J-Y, Ostoros, G, Cobo, M, Ciuleanu, T, McCormack, R, Webster, A, Milenkova, T
出版 2014

Cardiomyopathies and Arrhythmias Induced by Cancer Therapies

由 Romitan, Dragoș-Mihai, Rădulescu, Dan, Berindan-Neagoe, Ioana, Stoicescu, Laurențiu, Grosu, Alin, Rădulescu, Liliana, Gulei, Diana, Ciuleanu, Tudor-Eliade
發表在 Biomedicines (2020)

Expression profiling of 21 biomolecules in locally advanced nasopharyngeal carcinomas of Caucasian patients

由 Krikelis, Dimitrios, Bobos, Mattheos, Karayannopoulou, Georgia, Resiga, Liliana, Chrysafi, Sofia, Samantas, Epaminontas, Andreopoulos, Dimitrios, Vassiliou, Vassilios, Ciuleanu, Elisabeta, Fountzilas, George
出版 2013

A randomised double-blind placebo-controlled phase II study of AGI004 for control of chemotherapy-induced diarrhoea

由 Coyle, V M, Lungulescu, D, Toganel, C, Niculescu, A, Pop, S, Ciuleanu, T, Cebotaru, C, Devane, J, Martin, M, Wilson, R H
出版 2013

Treatment Patterns and Real-world Evidence for Stage III Non-small Cell Lung Cancer in Central and Eastern Europe

由 Zemanova, Milada, Jakopovic, Marko, Stanic, Karmen, Łazar-Poniatowska, Małgorzata, Vrankar, Martina, Rusu, Petronela, Ciuleanu, Tudor, Radosavljevic, Davorin, Bogos, Krisztina, Nawrocki, Sergiusz
發表在 Radiol Oncol (2020)

Gefitinib Treatment in EGFR Mutated Caucasian NSCLC: Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status

由 Douillard, Jean-Yves, Ostoros, Gyula, Cobo, Manuel, Ciuleanu, Tudor, Cole, Rebecca, McWalter, Gael, Walker, Jill, Dearden, Simon, Webster, Alan, Milenkova, Tsveta, McCormack, Rose
發表在 J Thorac Oncol (2014)

PD-029 Baseline carcinoembryonic antigen (CEA) as a predictive factor of ramucirumab efficacy in RAISE, a second-line metastatic colorectal carcinoma (mCRC) phase 3 trial

由 Yoshino, T., Obermannová, R., Bodoky, G., Garcia-Carbonero, R., Ciuleanu, T.-E., Portnoy, D., Kim Tae, W., Hsu, Y., Yang, L., Ferry, D., Nasroulah, F., Tabernero, J.
發表在 Ann Oncol (2016)

Access to Novel Drugs for Non‐Small Cell Lung Cancer in Central and Southeastern Europe: A Central European Cooperative Oncology Group Analysis

由 Cufer, Tanja, Ciuleanu, Tudor E., Berzinec, Peter, Galffy, Gabriela, Jakopovic, Marko, Jassem, Jacek, Jovanovic, Dragana, Mihaylova, Zhasmina, Ostoros, Gyula, Thallinger, Christiane, Zemanova, Milada, Zielinski, Christoph
發表在 Oncologist (2019)

Randomised Phase 2 study of maintenance linsitinib (OSI-906) in combination with erlotinib compared with placebo plus erlotinib after platinum-based chemotherapy in patients with a...

由 Ciuleanu, Tudor-Eliade, Ahmed, Samreen, Kim, Joo-Hang, Mezger, Jörg, Park, Keunchil, Thomas, Michael, Chen, Jihong, Poondru, Srinivasu, VanTornout, Jan M, Whitcomb, Debbie, Blackhall, Fiona
發表在 Br J Cancer (2017)

A multicenter, single-arm, basket design, phase II study of NC-6004 plus gemcitabine in patients with advanced unresectable lung, biliary tract, or bladder cancer

由 Volovat, Simona Ruxandra, Ciuleanu, Tudor-Eliade, Koralewski, Piotr, Olson, Juneko E. Grilley, Croitoru, Adina, Koynov, Krassimir, Stabile, Stefano, Cerea, Giulio, Osada, Atsushi, Bobe, Iulian, Volovat, Constantin
發表在 Oncotarget (2020)

Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergro...

由 Le Péchoux, C., Laplanche, A., Faivre-Finn, C., Ciuleanu, T., Wanders, R., Lerouge, D., Keus, R., Hatton, M., Videtic, G.M., Senan, S., Wolfson, A., Jones, R., Arriagada, R., Quoix, E., Dunant, A.
出版 2011

KRAS, NRAS and BRAF mutations in Greek and Romanian patients with colorectal cancer: a cohort study

由 Negru, Serban, Papadopoulou, Eirini, Apessos, Angela, Stanculeanu, Dana Lucia, Ciuleanu, Eliade, Volovat, Constantin, Croitoru, Adina, Kakolyris, Stylianos, Aravantinos, Gerasimos, Ziras, Nikolaos, Athanasiadis, Elias, Touroutoglou, Nikolaos, Pavlidis, Nikolaos, Kalofonos, Haralabos P, Nasioulas, George
出版 2014

Subgroup analysis in RAISE: a randomized, double-blind phase III study of irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) plus ramucirumab or placebo in patients with metast...

由 Obermannová, R., Van Cutsem, E., Yoshino, T., Bodoky, G., Prausová, J., Garcia-Carbonero, R., Ciuleanu, T., Garcia Alfonso, P., Portnoy, D., Cohn, A., Yamazaki, K., Clingan, P., Lonardi, S., Kim, T. W., Yang, L., Nasroulah, F., Tabernero, J.
發表在 Ann Oncol (2016)

Metronomic oral vinorelbine in previously untreated advanced non-small-cell lung cancer patients unfit for platinum-based chemotherapy: results of the randomized phase II Tempo Lun...

由 Camerini, A., Morabito, A., Montanino, A., Bernabé, R., Grossi, F., Ramlau, R., Ciuleanu, T.-E., Ceresoli, G.-L., Pasello, G., de Marinis, F., Bosch-Barrera, J., Laundreau, P., Gautier, S., Ta Thanh Minh, C., Kowalski, D.
發表在 ESMO Open (2021)

Association of baseline absolute neutrophil counts and survival in patients with metastatic colorectal cancer treated with second-line antiangiogenic therapies: exploratory analyse...

由 Grothey, Axel, Yoshino, Takayuki, Bodoky, Gyorgy, Ciuleanu, Tudor, Garcia-Carbonero, Rocio, García-Alfonso, Pilar, Van Cutsem, Eric, Muro, Kei, Mytelka, Daniel S, Li, Li, Lipkovich, Olga, Hsu, Yanzhi, Sashegyi, Andreas, Ferry, David, Nasroulah, Federico, Tabernero, Josep
發表在 ESMO Open (2018)

Dose escalation to rash for erlotinib plus gemcitabine for metastatic pancreatic cancer: the phase II RACHEL study

由 Van Cutsem, E, Li, C-P, Nowara, E, Aprile, G, Moore, M, Federowicz, I, Van Laethem, J-L, Hsu, C, Tham, C K, Stemmer, S M, Lipp, R, Zeaiter, A, Fittipaldo, A, Csutor, Z, Klughammer, B, Meng, X, Ciuleanu, T
發表在 Br J Cancer (2014)

A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients

由 Laquente, Berta, Lopez-Martin, Jose, Richards, Donald, Illerhaus, Gerald, Chang, David Z., Kim, George, Stella, Philip, Richel, Dirk, Szcylik, Cezary, Cascinu, Stefano, Frassineti, G. L., Ciuleanu, Tudor, Hurt, Karla, Hynes, Scott, Lin, Ji, Lin, Aimee Bence, Von Hoff, Daniel, Calvo, Emiliano
發表在 BMC Cancer (2017)

Analysis of angiogenesis biomarkers for ramucirumab efficacy in patients with metastatic colorectal cancer from RAISE, a global, randomized, double-blind, phase III study

由 Tabernero, J, Hozak, R R, Yoshino, T, Cohn, A L, Obermannova, R, Bodoky, G, Garcia-Carbonero, R, Ciuleanu, T -E, Portnoy, D C, Prausová, J, Muro, K, Siegel, R W, Konrad, R J, Ouyang, H, Melemed, S A, Ferry, D, Nasroulah, F, Van Cutsem, E
發表在 Ann Oncol (2018)